UPDATE 1-VBL to stop developing drug for psoriasis, ulcerative colitis

Feb 17 (Reuters) - Israel's VBL Therapeutics Inc said it would stop developing its experimental inflammatory drug to fight ulcerative colitis and psoriasis, sending its shares tumbling 45 percent...